908 Devices Inc. (MASS) Fair Value 2026

MASS · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-10-07, 908 Devices Inc. (MASS) trades at $12.33, versus a $11.12 median fair value across its 2 active models — 9.8% below the current price. QOC: 7.1/10. Value Trap Risk: 19/100 (SAFE). 2/13 models active.

Key Facts

Ticker
MASS
Price
$12.33
Quality Score
7.1/10
Value Trap Risk
19/100
Models Active
2/13
Last Updated
Strength: Regime Cross-Sectional suggests +8.7% upside with 44% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is 908 Devices Inc. (MASS) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, 908 Devices Inc. (MASS) appears fairly valued as of : the median of 2 independent fair value estimates is $11.12, within 9.8% of the current price of $12.33. Estimates range from $8.84 to $13.41. MASS scores 7.1/10 on fundamental quality and 19/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. MASS’s -9.8% gap is narrower than that market norm, and the Medical Devices sector median is -41.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy 908 Devices Inc. Stock in 2026? →

What Fair Value Does Each Model Give MASS?

2 Intrinsic Value Models vs. Current Price ($12.33)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Medium Conviction
 $13.41 +8.7%
Relative · Low Conviction
 $8.84 -28.3%

All Models Active

All 2 models are displayed above.

What Is 908 Devices Inc. (MASS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, 908 Devices Inc. presents a highly debated valuation profile at its current price of $12.33. The median intrinsic value is estimated at $11.12 (-9.8% median upside), masking a wide model spread between the 1 bullish models and 1 bearish models. Model dispersion is worth noting: Regime Cross targets $13.41 (+8.7%), versus FTNN at $8.84 (-28.3%). This +37.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About MASS?

2 of 13 models are currently active for MASS. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for MASS is $11.12 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does MASS Rank in Medical Devices?

Among 161 Medical Devices stocks, MASS ranks #50 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

908 Devices Inc.'s positioning within the Medical Devices segment means that clinical trial success rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.

Is MASS a Value Trap?

CirclFi's Value Trap algorithm assigns MASS a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for 908 Devices Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, 908 Devices Inc. earns a quality score of 7.1/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +37.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MASS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MASS's 2 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy 908 Devices Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

NVCRNovoCure LimitedQOC 7.1IRTCiRhythm Holdings, Inc.QOC 7.0LNSRLENSAR, Inc.QOC 7.1MXCTMaxCyte, Inc.QOC 7.0KIDSOrthoPediatrics Corp.QOC 7.1PRCTPROCEPT BioRobotics CorporationQOC 6.9NMTCNeuroOne Medical Technologies CorporationQOC 6.1FEEDENvue Medical, Inc.QOC 4.8INSPInspire Medical Systems, Inc.QOC 9.0IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: NVCR · IRTC · LNSR · MXCT · KIDS · PRCT · NMTC · FEED · INSP · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to MASS?

7 companies across all industries closest to MASS’s Quality of Company score of 7.1/10.

HDLSuper Hi International Holding Ltd.QOC 7.1SMTISanara MedTech Inc.QOC 7.1EQPTEquipmentShare.com Inc.QOC 7.1DBRGDigitalBridge Group, Inc.QOC 7.1ZTGZenta Group Company LimitedQOC 7.1STLYHG Holdings, Inc.QOC 7.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: HDL · SMTI · EQPT · DBRG · ZTG · STLY · NVDA

Where Does MASS Sit in CirclFi's Medical Devices Rankings?

MASS is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About 908 Devices Inc.’s Valuation?

What is 908 Devices Inc.'s intrinsic value in 2026?

CirclFi puts 908 Devices Inc. (MASS)'s intrinsic value at $11.12 — the median of 2 independent model estimates as of 2026-10-07, ranging from $8.84 to $13.41. The Quality of Company score is 7.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MASS overvalued or undervalued right now?

At $12.33, 1 of 2 active models suggest MASS may be undervalued, while 1 indicate potential overvaluation. The median of all 2 fair value estimates is $11.12, within 9.8% of the current price of $12.33 — a consensus view that MASS is fairly valued. The assessment depends on which methodology best fits 908 Devices Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.1 mean for MASS?

908 Devices Inc.'s QOC of 7.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on MASS?

CirclFi analyzes MASS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is MASS a value trap in 2026?

908 Devices Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, 908 Devices Inc. (MASS) has a median fair value of $11.12 — within 9.8% of the current price of $12.33 — as of 2026-10-07.” Source: circlfi.com/stock/MASS/ · Methodology
Primary sources for this MASS valuation
  • Financial statements: 908 Devices Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001555279) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MASS as of ; valuations recomputed .